Top Section/Ad
Top Section/Ad
Most recent
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
More articles/Ad
More articles/Ad
More articles
-
After weeks of slim pickings in high yield and leveraged loan capital markets, Monday brought a flood of new issue announcements, with MasMovil’s take-private loan, a multi-currency loan from cruise company Carnival, AMS’s bridge for the takeover of Osram, an add-on for IFCO, and a high yield debut in the morning. But that was all hors d'oeuvres to the main course: the long-awaited ThyssenKrupp Elevator bridge in the afternoon. -
Andrew Bailey, the governor of the Bank of England, has hinted at a dramatic reversal of the central bank’s long-standing monetary policy strategy, with the idea that it would be better to reduce the stock of its asset purchases before raising interest rates.
-
Italian prime minister Giuseppe Conte’s admission that Italy’s budget deficit would be wider than initially projected has caused a sell-off in the country’s bonds. The rest of the eurozone periphery has fared better, thanks in part to news of a new appointment to the German constitutional court.
-
The Portuguese treasury and debt management agency has unveiled its updated funding programme following the submission of its supplementary budget. The programme reveals the extent to which Portugal's borrowing needs have been elevated by the coronavirus crisis.
-
Chinese company Genertec Universal Medical Group has launched a $600m dual-currency loan into syndication.
-
Drug developer SK Biopharmaceuticals priced its IPO high last Friday, netting W959.3bn ($792m), according to a source close to the deal.
